CIDARA THERAPEUTICS INC

$CDTX
Institutional coverage

2 13F filers hold $CDTX.

13F holders
2
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

No exposure this quarter

No top-200 alpha managers currently hold $CDTX. The institutional holders table below shows the broader 13F picture.

Institutional holders

Top 2 of 2 · Source: 13F-HR
01
Vanguard Group Inc.
0.01% of portfolio
2,007,193 sh
02
Duquesne Family Office LLC
0.26% of portfolio
49,495 sh

Insider activity · last 90 days

50 transactions · 9 filers
07 Jan 2026
Merson James
· D
11,100
D
07 Jan 2026
Merson James
· D
2,125
D
07 Jan 2026
Merson James
· D
4,250
D
07 Jan 2026
Canale-Theakston Carin
· D
11,100
D
07 Jan 2026
Canale-Theakston Carin
· D
16,000
D
07 Jan 2026
Canale-Theakston Carin
· D
2,125
D
07 Jan 2026
Canale-Theakston Carin
· D
2,125
D
07 Jan 2026
Canale-Theakston Carin
· D
1,400
D
07 Jan 2026
Canale-Theakston Carin
· D
875
D
07 Jan 2026
Canale-Theakston Carin
· D
1,750
D
07 Jan 2026
Burgess Daniel D
· D
11,100
D
07 Jan 2026
Burgess Daniel D
· D
20,500
D

Transaction codes: P open-market purchase · S sale · M option exercise · A grant · F tax-withhold sale. Insider names link to each individual's expert page.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $CDTX in the recent window.

Convergence · $CDTX

active pattern signal
Pattern 04 · Hedge reversal
CDTX
CIDARA THERAPEUTICS INC 6 of top-10 funds exited · held through 2025-12-31 · exit Q 2026-03-31

Pattern cards reflect public SEC EDGAR and Congressional filing data only. Detection uses filing dates; trade execution dates may differ. Past convergence patterns do not predict future returns. Nothing here is investment advice.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 12:18 UTC.